Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2025 Filed Jun 14, 2025 00:14 UTC |
Dorval AllisonDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020360 · rdgdoc.xml · nonDerivative · entry 1 Dorval Allison · CIK 0001625110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,000 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 11, 2025 Filed Jun 14, 2025 00:10 UTC |
Cesano AlessandraDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020357 · rdgdoc.xml · nonDerivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,000 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 18:55 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 66,221 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001437749-25-003459 · rdgdoc.xml · derivative · entry 2 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,221 Underlying: Common Stock · 66,221 shares Expires 2035-02-06 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 18:55 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
GrantCommon Stock | 47,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-003459 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,792 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:58 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,067 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001437749-25-003461 · rdgdoc.xml · derivative · entry 2 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,067 Underlying: Common Stock · 85,067 shares Expires 2035-02-06 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:58 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
GrantCommon Stock | 61,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-003461 · rdgdoc.xml · nonDerivative · entry 1 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,751 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:53 UTC |
HUNT DOUGLAS MSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 66,604 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001437749-25-003456 · rdgdoc.xml · derivative · entry 2 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,604 Underlying: Common Stock · 66,604 shares Expires 2035-02-06 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:53 UTC |
HUNT DOUGLAS MSee Remarks
|
GrantCommon Stock | 48,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-003456 · rdgdoc.xml · nonDerivative · entry 1 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,711 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:51 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 274,622 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0001437749-25-003454 · rdgdoc.xml · derivative · entry 2 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,622 Underlying: Common Stock · 274,622 shares Expires 2035-02-06 F2 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 23:51 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantCommon Stock | 198,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-003454 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,228,073 F1 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 19:31 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
SaleCommon Stock | 9,437 | $3.15 | $29,742.59 |
DisclosureSEC source: 0001437749-25-000363 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,951 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:28 UTC |
HUNT DOUGLAS MSee Remarks
|
SaleCommon Stock | 8,633 | $3.15 | $27,208.63 |
DisclosureSEC source: 0001437749-25-000361 · rdgdoc.xml · nonDerivative · entry 1 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,594 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:33 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
SaleCommon Stock | 10,227 | $3.15 | $32,232.44 |
DisclosureSEC source: 0001437749-25-000365 · rdgdoc.xml · nonDerivative · entry 1 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,295 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:12 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
SaleCommon Stock | 33,841 | $3.15 | $106,656.68 |
DisclosureSEC source: 0001437749-25-000359 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,029,674 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 01:09 UTC |
MILLER MICHAEL PATRICKDirector
|
SaleCommon Stock | 23,358 | $3.49 | $81,465.70 |
DisclosureSEC source: 0001437749-24-026536 · rdgdoc.xml · nonDerivative · entry 1 MILLER MICHAEL PATRICK · CIK 0001236514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 19:06 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
SaleCommon Stock | 2,598 | $3.70 | $9,615.46 |
DisclosureSEC source: 0001437749-24-023020 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,388 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 23:11 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
SaleCommon Stock | 4,156 | $3.70 | $15,381.77 |
DisclosureSEC source: 0001437749-24-023022 · rdgdoc.xml · nonDerivative · entry 1 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,522 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 22:57 UTC |
HUNT DOUGLAS MSee Remarks
|
SaleCommon Stock | 3,637 | $3.70 | $13,460.90 |
DisclosureSEC source: 0001437749-24-023017 · rdgdoc.xml · nonDerivative · entry 1 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,227 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 22:50 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
SaleCommon Stock | 21,920 | $3.70 | $81,128.11 |
DisclosureSEC source: 0001437749-24-023014 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,063,515 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 21:19 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
SaleCommon Stock | 6,051 | $3.27 | $19,777.69 |
DisclosureSEC source: 0001437749-24-022065 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,986 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 01:22 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
SaleCommon Stock | 5,295 | $3.27 | $17,306.71 |
DisclosureSEC source: 0001437749-24-022067 · rdgdoc.xml · nonDerivative · entry 1 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,678 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 01:15 UTC |
HUNT DOUGLAS MSee Remarks
|
SaleCommon Stock | 4,349 | $3.27 | $14,214.71 |
DisclosureSEC source: 0001437749-24-022063 · rdgdoc.xml · nonDerivative · entry 1 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,864 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 01:10 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
SaleCommon Stock | 18,885 | $3.27 | $61,725.62 |
DisclosureSEC source: 0001437749-24-022061 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,085,435 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:25 UTC |
Stuglik Brian MDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021022 · rdgdoc.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,058 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:27 UTC |
WILSON TROY EDWARDDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021024 · rdgdoc.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,350 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:22 UTC |
Senderowicz AdrianDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021020 · rdgdoc.xml · nonDerivative · entry 1 Senderowicz Adrian · CIK 0001616230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:21 UTC |
MILLER MICHAEL PATRICKDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021018 · rdgdoc.xml · nonDerivative · entry 1 MILLER MICHAEL PATRICK · CIK 0001236514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,358 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:19 UTC |
MOYES JAY MDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021016 · rdgdoc.xml · nonDerivative · entry 1 MOYES JAY M · CIK 0001191062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,322 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:17 UTC |
Dorval AllisonDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021014 · rdgdoc.xml · nonDerivative · entry 1 Dorval Allison · CIK 0001625110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2024 Filed Jun 22, 2024 01:16 UTC |
Cesano AlessandraDirector
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021012 · rdgdoc.xml · nonDerivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,000 F1 · price: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:25 UTC |
Stuglik Brian MDirector
|
SaleCommon Stock | 9,900 | $3.39 | $33,528.33 |
DisclosureSEC source: 0001437749-24-020572 · rdgdoc.xml · nonDerivative · entry 1 Stuglik Brian M · CIK 0001716328 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,058 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-16-2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:27 UTC |
WILSON TROY EDWARDDirector
|
SaleCommon Stock | 27,000 | $3.33 | $89,901.90 |
DisclosureSEC source: 0001437749-24-020574 · rdgdoc.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:23 UTC |
Senderowicz AdrianDirector
|
SaleCommon Stock | 27,000 | $3.33 | $89,818.20 |
DisclosureSEC source: 0001437749-24-020570 · rdgdoc.xml · nonDerivative · entry 1 Senderowicz Adrian · CIK 0001616230 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:21 UTC |
MOYES JAY MDirector
|
SaleCommon Stock | 22,000 | $3.34 | $73,466.80 |
DisclosureSEC source: 0001437749-24-020568 · rdgdoc.xml · nonDerivative · entry 1 MOYES JAY M · CIK 0001191062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,322 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 23:18 UTC |
Dorval AllisonDirector
|
SaleCommon Stock | 11,000 | $3.37 | $37,096.40 |
DisclosureSEC source: 0001437749-24-020566 · rdgdoc.xml · nonDerivative · entry 1 Dorval Allison · CIK 0001625110 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,000 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 03-06-2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 01:01 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 9,047 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008575 · rdgdoc.xml · derivative · entry 2 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,047 Underlying: Common Stock · 9,047 shares Expires 2034-03-14 F1 · shares: Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards. F3 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 01:01 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantCommon Stock | 6,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008575 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,104,320 F1 · shares: Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards. F2 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 18:00 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,466 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001437749-24-004214 · rdgdoc.xml · derivative · entry 2 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,466 Underlying: Common Stock · 37,466 shares Expires 2034-02-11 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 18:00 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
GrantCommon Stock | 27,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004214 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,037 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:03 UTC |
Wong Alvin FChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 59,946 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001437749-24-004218 · rdgdoc.xml · derivative · entry 2 Wong Alvin F · CIK 0001868855 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,946 Underlying: Common Stock · 59,946 shares Expires 2034-02-11 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:03 UTC |
Wong Alvin FChief Scientific Officer
|
GrantCommon Stock | 43,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004218 · rdgdoc.xml · nonDerivative · entry 1 Wong Alvin F · CIK 0001868855 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,241 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:01 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 59,946 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001437749-24-004216 · rdgdoc.xml · derivative · entry 2 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,946 Underlying: Common Stock · 59,946 shares Expires 2034-02-11 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:01 UTC |
NOUGUES MAXIMO FChief Financial Officer
|
GrantCommon Stock | 43,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004216 · rdgdoc.xml · nonDerivative · entry 1 NOUGUES MAXIMO F · CIK 0001758507 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,973 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:58 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 222,573 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001437749-24-004211 · rdgdoc.xml · derivative · entry 2 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,573 Underlying: Common Stock · 222,573 shares Expires 2034-02-11 F2 · derivative.exercise_date: Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:58 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
GrantCommon Stock | 160,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004211 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,097,743 F1 · shares: Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:54 UTC |
HUNT DOUGLAS MSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 52,452 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001437749-24-004207 · rdgdoc.xml · derivative · entry 2 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,452 Underlying: Common Stock · 52,452 shares Expires 2034-02-11 F2 · derivative.exercise_date: Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:54 UTC |
HUNT DOUGLAS MSee Remarks
|
GrantCommon Stock | 37,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004207 · rdgdoc.xml · nonDerivative · entry 1 HUNT DOUGLAS M · CIK 0001727172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,213 F1 · shares: Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 19:00 UTC |
Ludwig Jeffrey JeromeChief Commercial Officer
|
SaleCommon Stock | 12,956 | $4.49 | $58,119.32 |
DisclosureSEC source: 0001437749-24-000773 · rdgdoc.xml · nonDerivative · entry 1 Ludwig Jeffrey Jerome · CIK 0001807133 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,970 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 00:03 UTC |
Wong Alvin FChief Scientific Officer
|
SaleCommon Stock | 7,733 | $4.49 | $34,689.46 |
DisclosureSEC source: 0001437749-24-000776 · rdgdoc.xml · nonDerivative · entry 1 Wong Alvin F · CIK 0001868855 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,214 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 23:56 UTC |
AUERBACH ALAN HDirector · President and CEO · 10% owner
|
SaleCommon Stock | 41,396 | $4.49 | $185,698.32 |
DisclosureSEC source: 0001437749-24-000770 · rdgdoc.xml · nonDerivative · entry 1 AUERBACH ALAN H · CIK 0001358285 · Director · President and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,936,947 F1 · kind: Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.